Longeveron Inc. (LGVN)
NASDAQ: LGVN · Real-Time Price · USD
0.7600
-0.0100 (-1.30%)
Jun 2, 2026, 4:00 PM EDT - Market closed
Longeveron Market Cap
Longeveron has a market cap or net worth of $22.25 million as of June 3, 2026. Its market cap has increased by 4.41% in one year.
Market Cap
22.25M
Enterprise Value
7.24M
1-Year Change
4.41%
Ranking
Category
Stock Price
$0.76
Market Cap Chart
Since the IPO on February 12, 2021, Longeveron's market cap has decreased from $172.48M to $22.25M, a decrease of -87.10%. That is a compound annual growth rate of -32.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 22.25M | 106.16% |
| Dec 31, 2025 | 10.79M | -57.95% |
| Dec 31, 2024 | 25.67M | -24.83% |
| Dec 29, 2023 | 34.15M | -49.55% |
| Dec 30, 2022 | 67.68M | -72.36% |
| Dec 31, 2021 | 244.90M | 41.99% |
| Feb 12, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vistagen Therapeutics | 25.65M |
| Marker Therapeutics | 25.50M |
| Pasithea Therapeutics | 23.89M |
| Cellectar Biosciences | 23.74M |
| VYNE Therapeutics | 22.75M |
| Werewolf Therapeutics | 22.65M |
| Traws Pharma | 22.27M |
| CEL-SCI | 21.45M |